User:IntentionallyDense/sandbox3

{{User sandbox}}

{{-}}

{{Infobox medical condition

|name = Vasculitis

|synonyms = Vasculitides{{cite web|url=http://www.merriam-webster.com/dictionary/Vasculitis|title=Vasculitis — Definition |website=Merriam-Webster Online Dictionary|access-date=2009-01-08|url-status=live|archive-url=https://web.archive.org/web/20160701173404/http://www.merriam-webster.com/dictionary/vasculitis|archive-date=2016-07-01}}

|image = HSP_Vasculitis.jpg

|caption = Petechia and purpura on the lower limb due to infection-associated vasculitis.

|width =

|pronounce = {{IPAc-en|v|æ|s|k|j|ʊ|ˈ|l|aɪ|t|ɪ|s}}

|specialty =

|symptoms =

|complications =

|onset =

|duration =

|types =

|causes =

|risks =

|diagnosis =

|differential =

|prevention =

|treatment =

|medication =

|prognosis =

|frequency =

|deaths =

|named after =

}}

Vasculitis refers to the inflammation and destruction of blood vessels. Vasculitides are an uncommon and diverse group of disorders.{{cite book | last=Micheletti | first=Robert G. | last2=Merkel | first2=Peter A. | title=Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology | chapter=Vasculitis | publisher=Springer International Publishing | publication-place=Cham | date=2022 | isbn=978-3-319-18445-6 | doi=10.1007/978-3-319-18446-3_8 | page=179–198}}

Signs and symptoms

The clinical presentation of the various vasculitides on the skin and internal organs is mostly determined by the diameter or size of the vessels mainly affected.{{cite book | last=Sunderkötter | first=Cord | title=Braun-Falco´s Dermatology | chapter=Vasculitis and Vasculopathies | publisher=Springer Berlin Heidelberg | publication-place=Berlin, Heidelberg | date=2022 | isbn=978-3-662-63708-1 | doi=10.1007/978-3-662-63709-8_64 | page=1125–1169}} Non-specific symptoms are common and include fever, headache, fatigue, myalgia, weight loss, and arthralgia.{{cite book |last1=Luqmani |first1=Raashid |last2=Robson |first2=Joanna |last3=Suppiah |first3=Ravi |editor1-last=Davey |editor1-first=Patrick |editor2-last=Sprigings |editor2-first=David |title=Diagnosis and Treatment in Internal Medicine |date=August 2018 |publisher=Oxford University Press |isbn=978-0-19-956874-1 |pages=927-931 |url=https://books.google.ca/books/about/Diagnosis_and_Treatment_in_Internal_Medi.html?id=hWFmDwAAQBAJ&redir_esc=y |access-date=8 August 2024 |chapter=272: Vasculitis}}{{cite journal | last=Jayne | first=David | title=The diagnosis of vasculitis | journal=Best Practice & Research Clinical Rheumatology | volume=23 | issue=3 | date=2009 | doi=10.1016/j.berh.2009.03.001 | pages=445–453}}

All forms of vasculitis, even large vessel vasculitides, may cause skin manifestations. The most common skin manifestations include purpura, nodules, livedo reticularis, skin ulcers, and purpuric urticaria.{{cite journal | last=Shavit | first=Eran | last2=Alavi | first2=Afsaneh | last3=Sibbald | first3=R. Gary | title=Vasculitis—What Do We Have to Know? A Review of Literature | journal=The International Journal of Lower Extremity Wounds | volume=17 | issue=4 | date=2018 | issn=1534-7346 | doi=10.1177/1534734618804982 | pages=218–226}}

class="wikitable"

|+

!Type

!Name

!Main symptoms

rowspan="2" |Primary large vessel vasculitis{{cite journal |last=Jennette |first=J. Charles |date=27 September 2013 |title=Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides |journal=Clinical and Experimental Nephrology |publisher=Springer Science and Business Media LLC |volume=17 |issue=5 |pages=603–606 |doi=10.1007/s10157-013-0869-6 |issn=1342-1751 |pmc=4029362 |pmid=24072416}}

|Takayasu arteritis

|Diminished or absent pulses, vascular bruits, hypertension, Takayasu retinopathy, and aortic regurgitation.{{cite journal | last=Johnston | first=S L | last2=Lock | first2=R J | last3=Gompels | first3=M M | title=Takayasu arteritis: a review | journal=Journal of Clinical Pathology | publisher=BMJ Publishing Group | volume=55 | issue=7 | date=2024-03-14 | pmid=12101189 | doi=10.1136/jcp.55.7.481 | url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769710/ | access-date=2024-08-18 | page=}}

Giant cell arteritis

|Headache, scalp tenderness, jaw claudication, and blindness.{{cite journal | last=Hoffman | first=Gary S. | title=Giant Cell Arteritis | journal=Annals of Internal Medicine | volume=165 | issue=9 | date=2016-11-01 | issn=0003-4819 | doi=10.7326/AITC201611010 | page=ITC67}}

rowspan="2" |Primary medium vessel vasculitis

|Polyarteritis nodosa

|Mononeuritis multiplex, nodules, purpura, livedo, and hypertension.{{cite journal | last=Forbess | first=Lindsy | last2=Bannykh | first2=Serguei | title=Polyarteritis Nodosa | journal=Rheumatic Disease Clinics of North America | volume=41 | issue=1 | date=2015 | doi=10.1016/j.rdc.2014.09.005 | pages=33–46}}

Kawasaki disease

|Fever, conjunctivitis, exanthema, palmoplantar erythema, cervical lymphadenopathy, and mucosal enanthema.{{cite journal | last=Son | first=M. B. F. | last2=Newburger | first2=J. W. | title=Kawasaki Disease | journal=Pediatrics in Review | volume=34 | issue=4 | date=2013-04-01 | issn=0191-9601 | doi=10.1542/pir.34-4-151 | pages=151–162}}{{cite journal | last=Hedrich | first=Christian M. | last2=Schnabel | first2=Anja | last3=Hospach | first3=Toni | title=Kawasaki Disease | journal=Frontiers in Pediatrics | volume=6 | date=2018-07-10 | issn=2296-2360 | pmid=30042935 | pmc=6048561 | doi=10.3389/fped.2018.00198 | doi-access=free | page=}}

rowspan="3" |Primary small vessel antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

|Microscopic polyangiitis

|Focal segmental rapidly progressive glomerulonephritis, proteinuria, hemoptysis, palpable purpura, abdominal pain, and peripheral neuropathy.{{cite journal | last=Chung | first=Sharon A. | last2=Seo | first2=Philip | title=Microscopic Polyangiitis | journal=Rheumatic Disease Clinics of North America | volume=36 | issue=3 | date=2010 | pmid=20688249 | pmc=2917831 | doi=10.1016/j.rdc.2010.04.003 | pages=545–558}}

Granulomatosis with polyangiitis

|Crusting rhinorrhea, sinusitis, chronic otitis

media, nasal obstruction, shortness of breath, and chronic cough.{{cite journal | last=Comarmond | first=Cloé | last2=Cacoub | first2=Patrice | title=Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment | journal=Autoimmunity Reviews | volume=13 | issue=11 | date=2014 | doi=10.1016/j.autrev.2014.08.017 | pages=1121–1125}}{{cite journal | last=Grygiel-Górniak | first=Bogna | last2=Limphaibool | first2=Nattakarn | last3=Perkowska | first3=Katarzyna | last4=Puszczewicz | first4=Mariusz | title=Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features | journal=Postgraduate Medicine | volume=130 | issue=7 | date=2018-10-03 | issn=0032-5481 | doi=10.1080/00325481.2018.1503920 | pages=581–596}}

Eosinophilic granulomatosis with polyangiitis

|Asthma, allergic rhinitis, sinusitis, nasal polyps, peripheral neuropathy, pulmonary infiltrates, and abdominal pain.{{cite journal | last=Vaglio | first=A. | last2=Buzio | first2=C. | last3=Zwerina | first3=J. | title=Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art | journal=Allergy | volume=68 | issue=3 | date=2013 | issn=0105-4538 | doi=10.1111/all.12088 | pages=261–273}}{{cite journal | last=White | first=Jpe | last2=Dubey | first2=S. | title=Eosinophilic granulomatosis with polyangiitis: A review | journal=Autoimmunity Reviews | volume=22 | issue=1 | date=2023 | doi=10.1016/j.autrev.2022.103219 | page=103219}}

rowspan="4" |Primary immune complex small vessel vasculitis

|Anti-glomerular basement membrane disease

|Glomerulonephritis, lung hemorrhage, hematuria, hemoptysis, cough, and dyspnea.{{cite journal | last=Bharati | first=Joyita | last2=Jhaveri | first2=Kenar D. | last3=Salama | first3=Alan D. | last4=Oni | first4=Louise | title=Anti–Glomerular Basement Membrane Disease: Recent Updates | journal=Advances in Kidney Disease and Health | volume=31 | issue=3 | date=2024 | doi=10.1053/j.akdh.2024.04.007 | pages=206–215}}

Cryoglobulinemic vasculitis

|Palpable purpura, Raynaud's phenomenon, joint pain,{{cite journal | last=Silva | first=Filipa | last2=Pinto | first2=Claudemira | last3=Barbosa | first3=Arsénio | last4=Borges | first4=Tiago | last5=Dias | first5=Carlos | last6=Almeida | first6=Jorge | title=New insights in cryoglobulinemic vasculitis | journal=Journal of Autoimmunity | volume=105 | date=2019 | doi=10.1016/j.jaut.2019.102313 | page=102313}} and peripheral neuropathy.

IgA vasculitis

|Palpable purpura, arthralgia, abdominal pain, nephritis, and haematuria.{{cite journal | last=Pillebout | first=Evangéline | last2=Sunderkötter | first2=Cord | title=IgA vasculitis | journal=Seminars in Immunopathology | volume=43 | issue=5 | date=2021 | issn=1863-2297 | doi=10.1007/s00281-021-00874-9 | pages=729–738}}

Hypocomplementemic urticarial vasculitis

|Hives, arthralgia, membranoproliferative glomerulonephritis, and chronic obstructive pulmonary disease.{{cite journal | last=Gu | first=Stephanie L. | last2=Jorizzo | first2=Joseph L. | title=Urticarial vasculitis | journal=International Journal of Women's Dermatology | volume=7 | issue=3 | date=2021 | pmid=34222586 | pmc=8243153 | doi=10.1016/j.ijwd.2021.01.021 | pages=290–297}}

rowspan="2" |Primary variable vessel vasculitis

|Behcet’s disease

|Oral ulcers, genital ulcers, papulopustular lesions, uveitis, superficial venous thrombosis and deep vein thrombosis.{{cite journal | last=Bettiol | first=Alessandra | last2=Prisco | first2=Domenico | last3=Emmi | first3=Giacomo | title=Behçet: the syndrome | journal=Rheumatology | volume=59 | issue=Supplement_3 | date=2020-05-01 | issn=1462-0324 | doi=10.1093/rheumatology/kez626 | pages=iii101–iii107}}

Cogan’s syndrome

|Interstitial keratitis, ocular redness, vertigo, and tinnitus.{{cite journal | last=Iliescu | first=Daniela Adriana | last2=Timaru | first2=Cristina Mihaela | last3=Batras | first3=Mehdi | last4=Simone | first4=Algerino De | last5=Stefan | first5=Cornel | title=COGAN’S SYNDROME | journal=Romanian Journal of Ophthalmology | publisher=Romanian Society of Ophthalmology | volume=59 | issue=1 | date=2024-03-14 | pmid=27373108 | url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729811/ | access-date=2024-08-19 | page=}}

rowspan="4" |Single-organ vasculitis{{cite journal |last=Martins-Martinho |first=Joana |last2=Dourado |first2=Eduardo |last3=Khmelinskii |first3=Nikita |last4=Espinosa |first4=Pablo |last5=Ponte |first5=Cristina |date=2021 |title=Localized Forms of Vasculitis |journal=Current Rheumatology Reports |volume=23 |issue=7 |page= |doi=10.1007/s11926-021-01012-y |issn=1523-3774 |pmc=8247627 |pmid=34196889}}

|Cutaneous small-vessel vasculitis

|Palpable purpura, necrosis, ulceration, bullae, and nodules.{{cite journal | last=Russell | first=James P. | last2=Gibson | first2=Lawrence E. | title=Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment | journal=International Journal of Dermatology | volume=45 | issue=1 | date=2006 | issn=0011-9059 | doi=10.1111/j.1365-4632.2005.02898.x | pages=3–13}}

Cutaneous arteritis

|Nodules, livedo reticularis, ulcers, and gangrene.{{cite journal | last=Furukawa | first=Fukumi | title=Cutaneous Polyarteritis Nodosa: An Update | journal=Annals of Vascular Diseases | publisher=Editorial Committee of Annals of Vascular Diseases | volume=5 | issue=3 | date=2012 | pmid=23555526 | doi=10.3400/avd.ra.12.00061 | url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595843/ | access-date=2024-08-19 | page=}}

Primary central nervous system vasculitis

|Headache, cognitive impairment, stroke, encephalopathy, and seizures.{{cite journal | last=Junek | first=Mats | last2=Perera | first2=Kanjana S | last3=Kiczek | first3=Matthew | last4=Hajj-Ali | first4=Rula A | title=Current and future advances in practice: a practical approach to the diagnosis and management of primary central nervous system vasculitis | journal=Rheumatology Advances in Practice | volume=7 | issue=3 | date=2023-08-26 | issn=2514-1775 | pmid=38091383 | pmc=10712448 | doi=10.1093/rap/rkad080 | page=}}

|

Retinal vasculitis

|Visual impairments, floaters, and macular edema.{{cite journal | last=Abu El-Asrar | first=Ahmed M. | last2=Herbort | first2=Carl P. | last3=Tabbara | first3=Khalid F. | title=Retinal Vasculitis | journal=Ocular Immunology and Inflammation | volume=13 | issue=6 | date=2005 | issn=0927-3948 | doi=10.1080/09273940591003828 | pages=415–433}}

rowspan="2" |Secondary vasculitis

|Lupus vasculitis

|Palpable purpura, petechiae, papulonodular lesions, urticaria lesions, and mononeuritis multiplex.{{cite journal | last=Leone | first=Patrizia | last2=Prete | first2=Marcella | last3=Malerba | first3=Eleonora | last4=Bray | first4=Antonella | last5=Susca | first5=Nicola | last6=Ingravallo | first6=Giuseppe | last7=Racanelli | first7=Vito | title=Lupus Vasculitis: An Overview | journal=Biomedicines | publisher=MDPI AG | volume=9 | issue=11 | date=2021-11-05 | issn=2227-9059 | doi=10.3390/biomedicines9111626 | doi-access=free | page=1626}}

Rheumatoid vasculitis

|Purpura, focal digital lesions, ulcers, digital necrosis, pyoderma, distal sensory or motor neuropathy, and mononeuritis multiplex.{{cite journal | last=Bartels | first=Christie M. | last2=Bridges | first2=Alan J. | title=Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments? | journal=Current Rheumatology Reports | publisher=Springer Science and Business Media LLC | volume=12 | issue=6 | date=2010-09-15 | issn=1523-3774 | doi=10.1007/s11926-010-0130-1 | pages=414–419}}

|

Causes

= Risk factors =

= Triggers =

= Genetics =

= Virology =

Mechanism

Diagnosis

Treatment

Outlook

Epidemiology

class="wikitable"

|+

!Type

!Age

!Sex

!Ethnic differences

!Incidence

!Prevalence

Takayasu arteritis

|25 ± 12.5{{cite journal | last=Alnabwani | first=Dina | last2=Patel | first2=Palak | last3=Kata | first3=Priyaranjan | last4=Patel | first4=Vraj | last5=Okere | first5=Arthur | last6=Cheriyath | first6=Pramil | title=The Epidemiology and Clinical Manifestations of Takayasu Arteritis: A Descriptive Study of Case Reports | journal=Cureus | publisher=Springer Science and Business Media LLC | date=2021-09-15 | issn=2168-8184 | doi=10.7759/cureus.17998 | page=}}

|88.3% female, 11.6 % male

|More common in Southeast Asia{{cite journal | last=Watts | first=Richard A. | last2=Hatemi | first2=Gulen | last3=Burns | first3=Jane C. | last4=Mohammad | first4=Aladdin J. | title=Global epidemiology of vasculitis | journal=Nature Reviews Rheumatology | publisher=Springer Science and Business Media LLC | volume=18 | issue=1 | date=2021-12-01 | issn=1759-4790 | doi=10.1038/s41584-021-00718-8 | pages=22–34}}

|Annual 0.4 - 3.4 per million

|8.4 - 40 per million

Giant cell arteritis

|71-80 years{{cite journal | last=Sharma | first=Ankita | last2=Mohammad | first2=Aladdin J. | last3=Turesson | first3=Carl | title=Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review | journal=Seminars in Arthritis and Rheumatism | publisher=Elsevier BV | volume=50 | issue=5 | year=2020 | issn=0049-0172 | doi=10.1016/j.semarthrit.2020.07.005 | pages=1040–1048}}

|Female to male ratio of 3:1

|More common in Caucasians.{{cite book | last=Watts | first=Richard A. | last2=Scott | first2=David G.I. | title=Oxford Textbook of Vasculitis | chapter=Epidemiology of vasculitis | publisher=Oxford University Press | date=2014 | isbn=978-0-19-965986-9 | doi=10.1093/med/9780199659869.003.0002 | page=6–25}}

|Annual 15–35 per 100 000 individuals 50< years

|84 - 250 per 100,000

Polyarteritis nodosa

|40–60 years

|male-to-female ratio of 1.5:1

|None

|Annual incidence of 0.9–8.0 per million

|31 per million

Kawasaki disease

|<5 years

|Male to female ratio of 1.5:1{{cite journal | last=Rowley | first=Anne H. | last2=Shulman | first2=Stanford T. | title=The Epidemiology and Pathogenesis of Kawasaki Disease | journal=Frontiers in Pediatrics | volume=6 | date=2018-12-11 | issn=2296-2360 | pmid=30619784 | pmc=6298241 | doi=10.3389/fped.2018.00374 | doi-access=free | page=}}

|More common in Japan

|5 - 22 per 100,000 children < 5 years old in North America, Europe, and Australia. > 50 per 100,000 children < 5 years old in Japan, South Korea and Taiwan.{{cite journal | last=Elakabawi | first=Karim | last2=Lin | first2=Jing | last3=Jiao | first3=Fuyong | last4=Guo | first4=Ning | last5=Yuan | first5=Zuyi | title=Kawasaki Disease: Global Burden and Genetic Background | journal=Cardiology Research | publisher=Elmer Press, Inc. | volume=11 | issue=1 | year=2020 | issn=1923-2829 | doi=10.14740/cr993 | pages=9–14}}

|

Microscopic polyangiitis

|66.98 ±13.12{{cite journal | last=Bataille | first=Pierre M. | last2=Durel | first2=Cécile-Audrey | last3=Chauveau | first3=Dominique | last4=Panes | first4=Arnaud | last5=Thervet | first5=Éric Simon | last6=Terrier | first6=Benjamin | title=Epidemiology of granulomatosis with polyangiitis and microscopic polyangiitis in adults in France | journal=Journal of Autoimmunity | publisher=Elsevier BV | volume=133 | year=2022 | issn=0896-8411 | doi=10.1016/j.jaut.2022.102910 | page=102910}}

|No difference.

|More common in Southern Europe.

|2.4 per million (Turkey) - 16 per million (USA).{{cite journal | last=Mohammad | first=Aladdin J | title=An update on the epidemiology of ANCA-associated vasculitis | journal=Rheumatology | volume=59 | issue=Supplement_3 | date=2020-05-01 | issn=1462-0324 | doi=10.1093/rheumatology/keaa089 | pages=iii42–iii50}}

|19.3 per million (Turkey) - 184 per million (USA).

Granulomatosis with polyangiitis

|55–69 years old.{{cite journal | last=Pearce | first=Fiona A. | last2=Grainge | first2=Matthew J. | last3=Lanyon | first3=Peter C. | last4=Watts | first4=Richard A. | last5=Hubbard | first5=Richard B. | title=The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink | journal=Rheumatology | date=2016-12-24 | issn=1462-0324 | doi=10.1093/rheumatology/kew413 | page=kew413}}

|Incidence higher in men.

|Incidence is higher amongst white people.

|11.8/million person-years.

|134.9 per million.

Eosinophilic granulomatosis with polyangiitis

|57.4±14.2

|

|

|1.2 per 1,000,000 person-years.{{cite journal | last=Hwee | first=Jeremiah | last2=Harper | first2=Lorraine | last3=Fu | first3=Qinggong | last4=Nirantharakumar | first4=Krishnarajah | last5=Mu | first5=George | last6=Jakes | first6=Rupert W. | title=Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK | journal=ERJ Open Research | volume=10 | issue=3 | date=2024 | issn=2312-0541 | pmid=38746859 | pmc=11089387 | doi=10.1183/23120541.00430-2023 | pages=00430–2023}}

|2.0–38.0 per 1,000,000 people.

Anti-glomerular basement membrane disease

|

|

|

|

|

Cryoglobulinemic vasculitis

|

|

|

|

|

IgA vasculitis

|<16 years

|

|

|

|

Hypocomplementemic urticarial vasculitis

|40–60 years

|

|

|

|

Behcet’s disease

|More common during the second and third decades

|

|

|

|

Cogan’s syndrome

|

|

|

|

|

Cutaneous small-vessel vasculitis

|

|

|

|

|

Cutaneous arteritis

|

|

|

|

|

Primary central nervous system vasculitis

|

|

|

|

|

Retinal vasculitis

|

|

|

|

|

Lupus vasculitis

|

|

|

|

|

Rheumatoid vasculitis

|

|

|

|

|

History

Society and culture

Special populations

= Geriatrics =

= Pregnancy =

= Children =

See also

References

{{reflist}}

Further reading